Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Vishal B Malkan of malkansview.com is of the view that one can sell IOC for a target price of Rs 320 and Titan Company for a target price of Rs 400.
Vishal B Malkan of malkansview.com recommends buying UPL for a target price of Rs 370 and CESC for a target price of Rs 750.
Meghana Malkan of malkansview.com suggests buying Ranbaxy Laboratories with a target of Rs 702-712 and UPL with a target of Rs 371-380.
Kunal Bothra of LKP Securities advises buying Bharat Forge with a target of Rs 940-950 and SKS Microfinance with a target of Rs 375.
Sudarshan Sukhani of s2analytics.com recommends buying CESC.
Manav Chopra, Nirmal Bang advises buying Bharat Forge for a target price of Rs 870 and Adani Power for a target price of Rs 54.
Kunal Saraogi of Equityrush advises buying Apollo Hospitals Enterprises with a target of Rs 1190 and Mahindra & Mahindra Financial Services with a target of Rs 316.
According to Hemant Thukral of Aditya Birla Money, CESC is a good trading bet and feels that GMR Infra may test Rs 22.80-23.
Sudarshan Sukhani of s2analytics.com is of the view that oen may see lower levels in CESC.
Meghana V Malkan of malkansview.com recommends selling Adani Enterprises with a target of Rs 475 and CESC with a target of Rs 748.
Meghana V Malkan, malkansview.com advises buying Ranbaxy Labs for a target price of Rs 615 and selling Reliance Capital for a target price of Rs 495.
Meghana V Malkan of malkansview.com is of the view that one can buy Exide Industries with a target of Rs 190 and Oriental Bank of Commerce with a target of Rs 305.
AK Prabhakar, Independent Advisor advises buying Eros International for a target price of Rs 300 and Bank of India for a target price of Rs 319.
Hemen Kapadia of KR Choksey Securities suggests selling ACC with a target of Rs 1495 and buying Just Dial with a target of Rs 1747.
Manish Hathiramani of Deen Dayal Investments is of the view that CESC may hit Rs 800.
Dhananjay Sinha, Head of Institutional Research at Emkay Global Financial Services recommends buying CESC.
Manav Chopra of Nirmal Bang recommends buying Rural Electrification Corporation for a target of Rs 290 and NTPC for a target of Rs 148.
Manav Chopra, Nirmal Bang advises buying Biocon for a target price of Rs 530 and CESC for a target price of Rs 790.
Vishal Malkan of malkansview.com is of the view that one can buy Tech Mahindra with a target of Rs 2380 and Divis Laboratories with a target of Rs 1,625.
Vishal Jajoo, Nirmal Bang Securities advises buying Kopran for a target price of Rs 65.50 and Jaiprakash Associates for a target price of Rs 55.75.
Pritesh Mehta, technical analyst of IIFL recommends buying CESC as the stock may touch Rs 485.
The company has nearly 24.9 lakh shares of CESC which are valued at around Rs 115 crore.
Vishal Malkan of Malkansview recommends buying IFCI with a target of Rs 26.50 and Havells India with a target of Rs 840.
Dharmesh Kant, Indianivesh Securities advises buying Arvind for a target price of Rs 165 and Federal Bank for a target price of Rs 90.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Dr Reddys Laboratoties, Havells India and CESC.